d'Oliveira & Associates Releases Transvaginal Mesh Infographic Explaining the Device’s High Risk of Failure

Share Article

The personal injury law firm has published a new infographic on the potential risks posed by Transvaginal Mesh when used to treat Pelvic Organ Prolapse and Stress Urinary Incontinence.

Transvaginal mesh was designed to permanently treat Pelvic Organ Prolapse (POP) and Stress Urinary Incontinence (SUI). These conditions are caused when a woman’s pelvic muscles are weakened and stretched during childbirth or during other incidents. Transvaginal mesh is a synthetic mesh that is implanted transvaginally to provide support for the abdominal organs. Side effects that have been associated with the transvaginal mesh include erosion and exposure of the mesh as well as recurrence of POP or SUI. The American College of Obstetricians and Gynecologists had to stop a transvaginal mesh clinical test early because the women taking part in the test experienced too many complications from the device.

Source:
http://journals.lww.com/greenjournal/Fulltext/2010/08000/Vaginal_Mesh_for_Prolapse__A_Randomized_Controlled.9.aspx

The infographic timeline details transvaginal mesh products from their introduction in 1996 by Boston Scientific until the product recall in 1999. Boston Scientific recalled the transvaginal mesh because it did not “produce outcomes consistent with the company’s standard of performance for its products or customer expectations.” Despite this recall and many early reports about the defective nature of the transvaginal mesh, manufacturers began marketing the device *(Bloomberg report on Boston Scientific and subsequent mesh prodcuts). The infographic also illustrates how the transvaginal mesh caused thousands of patients to file adverse event reports with the FDA. The same FDA event reports examined 110 studies including 11,785 women and determined that approximately 10 percent of women undergoing transvaginal POP repair with mesh experienced mesh erosion within 12 months of surgery **(2011 FDA safety update).

Sources:

** http://www.fda.gov/downloads/medicaldevices/safety/alertsandnotices/UCM262760.pdf

This new infographic from d’Oliveira & Associates provides important information about transvaginal mesh for patients implanted with this device from one of the 33 manufacturers that the FDA has ordered to conduct post-market studies.

Source:
http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/UroGynSurgicalMesh/default.htm

Visit the d’Oliveira & Associates website and view the Transvaginal Mesh Patch infographic: good-legal-advice.com/transvaginal-mesh.htm

Do You Have A Transvaginal Mesh Patch Claim?

If you or a loved one has been injured by a transvaginal mesh device, you may want to speak with a personal injury attorney regarding a potential claim. A lawyer familiar with new developments in the investigation of transvaginal mesh may be able to help you make important personal and legal decisions. d’Oliveira & Associates, P.C. is working with some of the leading medical device lawyers in the country who are handling these cases.

Please contact the law offices of d'Oliveira & Associates, P.C. at 1-800-992-6878 or fill out a contact form for a free legal consultation.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Paul d'Oliveira
Visit website